名臣健康(002919.SZ):已經收到嘉晟印務分紅款
格隆匯10月7日丨名臣健康(002919.SZ)公佈,公司全資子公司汕頭市嘉晟印務有限公司(“嘉晟印務”)於近日作出股東決定,以截至2020年12月31日的累計未分配利潤向公司進行現金分紅,具體情況如下:
截至2020年12月31日,嘉晟印務可供分配的利潤為9,768,800.32元。嘉晟印務以現金方式向股東分配利潤975萬元,佔可供分配利潤的99.81%,剩餘未分配利潤結轉下一年度。
截止公吿日,公司已經收到嘉晟印務分紅款。公司持有嘉晟印務100%股權,為公司納入合併報表範圍內的全資子公司,此次所得分紅將增加母公司2021年度淨利潤,但不增加公司2021年度合併報表淨利潤,因此不會影響2021 年度公司整體經營業績。敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.